Hyperparathyroidism epidemiology and demographics

Hyperparathyroidism Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hyperparathyroidism from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hyperparathyroidism epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hyperparathyroidism epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hyperparathyroidism epidemiology and demographics
CDC on Hyperparathyroidism epidemiology and demographics
Hyperparathyroidism epidemiology and demographics in the news
Blogs on Hyperparathyroidism epidemiology and demographics
Directions to Hospitals Treating Hyperparathyroidism
Risk calculators and risk factors for Hyperparathyroidism epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Epidemiology and Demographics

Incidence

• The incidence of hyperparathyroidism is approximately 0.4 to 21.6 per 100,000 person years.

Prevalence

• The prevalence of prolactinoma is approximately .01 to .07 per 100,000 individuals.

Age

• Patients of all age groups may develop [disease name].
• The incidence of primary hyperparathyroidism increases with age.
• In individuals age < 50 years, the incidence of primary hyperparathyroidism ranges from a low of 12 per 100,000 person years to a high of 24 per 100,000 per person years.
• [Chronic disease name] is usually first diagnosed among [age group].
• [Acute disease name] commonly affects [age group].

Race

• There is no racial predilection to [disease name].
• [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].

Gender

• Women are more commonly affected by hyperparathyroidism than men. The women to men ratio is approximately 3 to 1.
• In women, the incidence of primary hyperparathyroidism ranges from a low of 34 per 100,000 person years to a high of 120 per 100,000 person years with an average incidence of 66 per 100,000 person years.
• In men, the incidence of primary hyperparathyroidism ranges from a low of 13 per 100,000 person years to a high of 36 per 100,000 person years with an average incidence of 24 per 100,000 person years.
• Sex difference becomes more pronounced with advancing age.
  • Age < 50 years
    • Incidence is 12-24 per 100,000 person years in both sexes.
  • Age 50 - 59 years
    • Men: 36 per 100,000 person years
    • Women: 80 per 100,000 person years
  • Age 70-79 years
    • Men: 95 per 100,000 person years
    • Women: 196 per 100,000 person years

Region

• The majority of [disease name] cases are reported in [geographical region].

• [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].